LXEO – lexeo therapeutics, inc. (US:NASDAQ)

News

Lexeo Therapeutics (LXEO) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Will Lexeo Therapeutics (NASDAQ:LXEO) Spend Its Cash Wisely? [Yahoo! Finance]
Lexeo Therapeutics GAAP EPS of -$0.27 beats by $0.04 [Seeking Alpha]
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com